`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner,
`
`v.
`
`CIPLA LTD.
`Patent Owner.
`
`
`Case IPR2017-00807
`Patent No. 8,168,620 B2
`
`
`
`
`
`
`
`
`
`JOINT STIPULATION TO LIMIT PETITION UNDER 37 C.F.R. § 42.71
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`1
`
`CIP2182
`Argentum Pharmaceuticals v. Cipla Ltd.
`IPR2017-00807
`
`
`
`
`
`
`IPR2017-00807
`
`Stipulation to Limit Petition
`
`Pursuant 37 C.F.R. § 42.71 and an email communication authorizing this
`
`stipulation, Petitioner Argentum Pharmaceuticals LLC and Patent Owner Cipla
`
`Ltd. hereby provide notice of the following:
`
`WHEREAS the Petition (Paper 1) presented three grounds challenging the
`
`patentability of U.S. Patent No. 8,168,620: (1) Ground 1 alleging unpatentability of
`
`claims 1 and 25 under 35 U.S.C. § 102(b) over Segal; (2) Ground 2 alleging
`
`unpatentability of claims 1, 4-6, 24-26, and 29 under 35 U.S.C. § 103 over Hettche,
`
`Phillipps, and Segal; and (3) Ground 3 alleging unpatentability of claims 42-44
`
`under 35 U.S.C. § 103 over Hettche, Phillipps, Segal, and Flonase Label;
`
`WHEREAS the Board’s Decision (Paper 11) instituted review on Grounds 2
`
`and 3;
`
`WHEREAS the Board modified the Institution Decision (Paper 51) to
`
`institute “review of all challenged claims and all grounds presented in the
`
`Petition;”
`
`NOW THEREFORE, Petitioner and Patent Owner have agreed and stipulate,
`
`as follows:
`
`1. Petitioner and Patent Owner stipulate to dismiss Ground 1 presented in the
`
`Petition from this proceeding and to limit the Petition pursuant to 37 C.F.R. §
`
`42.71 to Grounds 2 and 3 only;
`
`
`
`- 1 -
`
`2
`
`CIP2182
`Argentum Pharmaceuticals v. Cipla Ltd.
`IPR2017-00807
`
`
`
`
`
`
`IPR2017-00807
`
`Stipulation to Limit Petition
`
`2. Petitioner and Patent Owner stipulate that this agreement shall not operate
`
`
`
`as a waiver or have any estoppel effect;
`
`3. Petitioner and Patent Owner stipulate that the sole intent of this agreement
`
`is to return this proceeding to the status quo before Paper 51 instituting review on
`
`all grounds presented in the Petition;
`
`4. Petitioner and Patent Owner stipulate that no additional briefing or
`
`evidence will be submitted concerning Ground 1, that Ground 1 will not be
`
`addressed at the upcoming oral hearing scheduled for May 16, 2018, and that the
`
`Board need not address Ground 1 in its final written decision.
`
`
`
`
`
`
`
`
`
`
`Date: May 11, 2018
`
`
`
`
`
`Date: May 11, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`/Michael Houston/
`Michael R. Houston
`Reg. No. 58,486
`Lead Attorney for Petitioner
`
`
`Respectfully submitted,
`
`
`
`/Dennies Varughese/
`Dennies Varughese
`Registration No. 61,868
`Lead Attorney for Patent Owner
`
`- 2 -
`
`3
`
`